NEW DELHI : Tech Mahindra expects to start trials for a Covid drug in the next three to four months after receiving the patent for a particular molecule, according to a senior official.
Markers Lab, the research and development arm of the IT company, is working on developing the drug. The company along with Reagene Biosciences has filed for the patent for a molecule that can be used to develop a drug against coronavirus. "We expect the trial to start in about three to four months.
The patent is still under process," Tech Mahindra Global Head (Makers Lab) Nikhil Malhotra told PTI. When asked about the timeline for the development of the drug, Malhotra said "one-and-a-half years is a safe time to assume but again it depends on the